Volume 16, Number 6—June 2010
Dispatch
Enterovirus Genotype EV-104 in Humans, Italy, 2008–2009
Table
Characteristics of 5 patients with HEV genotype EV-104 infection, Pavia, Italy, 2009*
Patient no. | Sample no. | Age, y/sex | Hospital department, date of admission | Respiratory secretion Ct value |
Clinical symptoms | Underlying disease | Virus identified/ coinfecting virus (Ct) | |
---|---|---|---|---|---|---|---|---|
HEV | HRV | |||||||
Pav-1 | NPA/9210 | 60/M | Hematology outpatient, Apr | 29.67 | Undetected | Fever, cough, rhinorrhea | HSCT (AML) | EV-104 |
Pav-2 | NPA/9570 | 62/M | Infectious Diseases outpatient, Apr | 23.06 | 23.05 | Chronic rhinopharyngitis | None | EV-104 |
Pav-3 | NPA/11228 | 7/F | Pediatric Oncohematology, May | 33.64 | Undetected | Fever, rhinorrhea, conjunctivitis | AML (chemotherapy) | EV-104 |
Pav-4 | NPA/11230 | 37/F | Infectious Diseases outpatient, May | 32.60 | Undetected | Chronic rhinopharyngitis | None | EV-104 |
Pav-5 | NPA/13174 | 2/M | Pediatric Oncohematology, Jun | 23.78 | 31.61 | Cough, rhinorrhea, diarrhea, wheezing | HSCT (AML) | EV-104/RSV (18.53) |
*HEV, human enterovirus; Ct, cycle threshold; HRV, human rhinovirus; NPA, nasopharyngeal aspirate; HSCT, hematopoietic stem cell transplant; AML, acute myelocytic leukemia; RSV, respiratory syncytial virus.